These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

993 related items for PubMed ID: 11242805

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effects of transjugular intrahepatic portosystemic shunt on portal hypertensive gastropathy.
    Urata J, Yamashita Y, Tsuchigame T, Hatanaka Y, Matsukawa T, Sumi S, Matsuno Y, Takahashi M.
    J Gastroenterol Hepatol; 1998 Oct; 13(10):1061-7. PubMed ID: 9835325
    [Abstract] [Full Text] [Related]

  • 6. Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein.
    Li ZP, Wang SS, Wang GC, Huang GJ, Cao JQ, Zhang CQ.
    Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):517-523. PubMed ID: 30262421
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Transjugular Intrahepatic Portosystemic Shunt (TIPS): Pathophysiologic Basics, Actual Indications and Results with Review of the Literature.
    Strunk H, Marinova M.
    Rofo; 2018 Aug; 190(8):701-711. PubMed ID: 30045395
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Transjugular intrahepatic portosystemic shunt prevents rebleeding in cirrhotic patients having cavernous transformation of the portal vein without improving their survival.
    Li LN, Sun XY, Wang GC, Tian XG, Zhang MY, Jiang KT, Zhang CQ.
    J Dig Dis; 2019 Feb; 20(2):89-96. PubMed ID: 30629804
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Recurrent variceal bleeding and shunt patency: prospective randomized controlled trial of transjugular intrahepatic portosystemic shunt alone or combined with coronary vein embolization.
    Chen S, Li X, Wei B, Tong H, Zhang MG, Huang ZY, Cao JW, Tang CW.
    Radiology; 2013 Sep; 268(3):900-6. PubMed ID: 23657891
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Transjugular intrahepatic portosystemic shunt with the Strecker stent for control of refractory acute and chronic variceal bleeding.
    Canizares RB, Rodriguez-Laiz JM, Martin MC, Belda AE, Alonso FC, Roldan FP, Castro LS, Arregui EC, Ricote GC.
    Scand J Gastroenterol; 1996 Mar; 31(3):285-93. PubMed ID: 8833360
    [Abstract] [Full Text] [Related]

  • 20. Incrementally Expandable Transjugular Intrahepatic Portosystemic Shunts: Single-Center Experience.
    Cui J, Smolinski SE, Liu F, Xu D, Dulaimy K, Irani Z.
    AJR Am J Roentgenol; 2018 Feb; 210(2):438-446. PubMed ID: 29261352
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.